Dr. Mauricio Mandel Brigido, MD, PhD

Dr. Mandel Brigido practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Mandel Brigido's NPI, 1982259461, was assigned on August 1, 2019. Dr. Mandel Brigido graduated from Univ Sao Paulo- Fac Med in 2004. Dr. Mandel Brigido holds Florida license ME147473.

Dr. Mandel Brigido's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Mandel Brigido's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. Dr. Mandel Brigido is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Mandel Brigido to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Mandel Brigido's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandel Brigido practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Mandel Brigido's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Mandel Brigido's licenses on file in 4 states: Florida, Connecticut, New York and California.

CMS data shows 239 Medicare services from Dr. Mandel Brigido across 5 procedure codes in 2024, for 202 Medicare patients. Medicare paid $33,065 for them.

CMS counts 202 Medicare patients who saw Dr. Mandel Brigido in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have arthritis, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mandel Brigido's median patient age at 67, with 57% women.

In 2024, Dr. Mandel Brigido wrote 27 Medicare Part D claims for 17 patients. 93% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mandel Brigido for performance year 2024, reported through an alternative payment model (APM). Dr. Mandel Brigido accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mandel Brigido as offering telehealth. CMS counts 41 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Mandel Brigido, more than 71% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Mandel Brigido to 1 clinical trial. Conditions studied include Intracranial Aneurysm and Intracranial Arterial Diseases.

CMS Open Payments shows 2 general payments to Dr. Mandel Brigido from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $19.

Dmand AI lists 1 award for Dr. Mandel Brigido, most recently Edmundo Vasconcelos Award - Best Student - Surgical disciplines in 2004.

Dr. Mandel Brigido graduated from Univ Sao Paulo- Fac Med in 2004. Dr. Mandel Brigido is a member of Congress of Neurological Surgeons.

Dr. Mandel Brigido is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.